November 19, 2026
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Uganda Launches Long-Acting HIV Prevention Drug Lenacapavir

April 18, 2026

The Ministry of Health Uganda has officially launched Lenacapavir, a groundbreaking injectable drug for HIV prevention, marking a significant step forward in the country’s fight against new infections.

The new intervention, unveiled on Friday, introduces a long-acting pre-exposure prophylaxis (PrEP) option administered just once every six months, offering a more convenient alternative to daily oral prevention methods.

Health Minister Jane Ruth Aceng Ocero described the rollout as a “historic milestone” in Uganda’s ambition to end AIDS as a public health threat by 2030.

“Lenacapavir represents a major advancement in HIV prevention. It expands choice and improves accessibility, especially for populations at higher risk,” she said during the launch.

Clinical trial evidence shows the drug is highly effective in preventing HIV infection when used as prescribed. However, officials emphasized that it does not protect against pregnancy or other sexually transmitted infections and will be offered alongside existing prevention methods such as condoms, safe medical circumcision, and oral PrEP.

Uganda has made notable progress in recent years, reducing new HIV infections from about 96,000 in 2010 to approximately 37,000 by the end of 2025. Despite these gains, the virus remains a major public health challenge, particularly among adolescent girls, young women, and other high-risk groups facing structural barriers such as stigma and limited access to healthcare.

The rollout will be implemented in phases, initially targeting high-burden districts. The Ministry has already trained healthcare workers in 103 facilities, which will begin offering the drug this month. By December 2026, the number of facilities providing Lenacapavir is expected to rise to 300 nationwide.

The initiative is supported by global partners, including the World Health Organization, Global Fund, and the United States government, alongside pharmaceutical company Gilead Sciences.

Speaking at the event, U.S. Deputy Chief of Mission Mikael Cleverley hailed Lenacapavir as a “groundbreaking innovation” and reaffirmed commitments to expand access. He noted that the U.S. and partners aim to reach three million people in high-burden countries with the drug by 2028.

Health officials say the introduction of Lenacapavir is expected to strengthen Uganda’s comprehensive HIV prevention strategy and accelerate progress toward ending the epidemic.

UN Security Council Pushes Secretary-General Straw Poll to Friday, Returns to Colour-Coded Ballots

5 hours ago

US, Venezuela Seal Military Cooperation Deal as Hegseth Visits Caracas

6 hours ago

US Lawmakers Warn Sanctions on Rwanda Could Undermine Trump’s DRC Peace Deal

7 hours ago

Carney, Trump Meet in China as Canada, US Seek Trade Deal

9 hours ago

Museveni, Suluhu Agree to Fast-Track EACOP, SGR Projects

11 hours ago

UN Security Council Pushes Secretary-General Straw Poll to Friday, Returns to Colour-Coded Ballots

US, Venezuela Seal Military Cooperation Deal as Hegseth Visits Caracas

US Lawmakers Warn Sanctions on Rwanda Could Undermine Trump’s DRC Peace Deal

Carney, Trump Meet in China as Canada, US Seek Trade Deal

Museveni, Suluhu Agree to Fast-Track EACOP, SGR Projects

Sudan Court Sentences RSF Leader Hemedti, Brother and 11 Others to Death

UN Security Council Pushes Secretary-General Straw Poll to Friday, Returns to Colour-Coded Ballots

5 hours ago
US, Venezuela Seal Military Cooperation Deal as Hegseth Visits Caracas

6 hours ago
US Lawmakers Warn Sanctions on Rwanda Could Undermine Trump’s DRC Peace Deal

7 hours ago
Carney, Trump Meet in China as Canada, US Seek Trade Deal

9 hours ago
Museveni, Suluhu Agree to Fast-Track EACOP, SGR Projects

11 hours ago
Sudan Court Sentences RSF Leader Hemedti, Brother and 11 Others to Death

12 hours ago
Sam Mugumya, Two Others Charged with Security, Treachery Offences over Alleged ADF Links

13 hours ago
Uganda Registers 34.9 Million Citizens, Cuts Passport Processing to Five Days

14 hours ago
Xi and Trump Share Surprise Embrace as US President Arrives in China

14 hours ago
Uganda Airlines Launches Daily Kigali Flights, Expands Network to 18 Destinations

14 hours ago
Museveni, Dangote Discuss Oil Refining, Fertiliser Production and Mining Investments

15 hours ago
Xi, Putin Discuss Global Security and Multipolar World Ahead of Trump Talks

16 hours ago

Uganda’s NRM, China’s CPC Deepen Party-to-Party Cooperation in Institutional Development

1 day ago

Eisenkot Calls for Probe into Alleged Election Rigging Involving Netanyahu’s Office

3 days ago

Eisenkot Accuses Netanyahu of Political Stalling, Says New Israeli Government Will Be Formed

4 days ago

Kremlin Confirms First-Ever Putin-Xi-Trump Trilateral Summit in China on November 19

4 days ago

UG Diplomat is an independent digital news and media platform dedicated to comprehensive coverage of national politics, regional diplomacy, international relations, geopolitics, defense, and business. Published under Currentarc Media Ltd, we provide authoritative analysis, breaking news, and in-depth reporting on the diplomatic and economic developments shaping East Africa and the global arena.

COMPANY

Contact Us

Privacy Policy

Terms and Conditions

CONTACT INFORMATION

info@ugdiplomat.com

+256774552385

Copyright © 2026 UG Diplomat -Product of CURRENTARC MEDIA